How to buy Fisher-and-Paykel Healthcare Corporation (FPH) shares in Australia
Learn how to easily invest in Fisher-and-Paykel Healthcare Corporation shares.
Fisher-and-Paykel Healthcare Corporation is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $1.7 billion. If you're looking to buy shares, check out the steps below.
How to buy shares in Fisher-and-Paykel Healthcare Corporation
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Fisher-and-Paykel Healthcare Corporation. Find the share by name or ticker symbol: FPH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fisher-and-Paykel Healthcare Corporation reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Fisher-and-Paykel Healthcare Corporation. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
What's in this guide?
- Fisher-and-Paykel Healthcare Corporation key stats
- Compare share trading platforms
- Is Fisher-and-Paykel Healthcare Corporation stock a buy or sell?
- Fisher-and-Paykel Healthcare Corporation performance over time
- Are Fisher-and-Paykel Healthcare Corporation shares over-valued?
- Fisher-and-Paykel Healthcare Corporation's financials
- How volatile are Fisher-and-Paykel Healthcare Corporation shares?
- Does Fisher-and-Paykel Healthcare Corporation pay a dividend?
- Have Fisher-and-Paykel Healthcare Corporation shares ever split?
- Other common questions
Fisher-and-Paykel Healthcare Corporation stock price (ASX:FPH)Use our graph to track the performance of FPH stocks over time.
Fisher-and-Paykel Healthcare Corporation shares at a glance
|52-week range||$18.426 - $25.6155|
|50-day moving average||$20.1722|
|200-day moving average||$22.1833|
|Dividend yield||$0.41 (1.53%)|
|Earnings per share (TTM)||$0.42|
Compare share trading platforms
Is it a good time to buy Fisher-and-Paykel Healthcare Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Fisher-and-Paykel Healthcare Corporation price performance over time
|1 week (2023-11-28)||5.54%|
|1 month (2023-11-03)||7.85%|
|3 months (2023-09-05)||4.57%|
|6 months (2023-06-05)||-2.16%|
|1 year (2022-12-05)||-5.40%|
|2 years (2021-12-03)||-29.50%|
|3 years (2020-12-04)||-29.48%|
|5 years (2018-12-05)||83.14%|
Is Fisher-and-Paykel Healthcare Corporation under- or over-valued?
Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fisher-and-Paykel Healthcare Corporation's P/E ratio
Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 52x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 52x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Fisher-and-Paykel Healthcare Corporation's PEG ratio
Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fisher-and-Paykel Healthcare Corporation's EBITDA
Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.4 million (£0.0 million).
The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure stock profitability.
Fisher-and-Paykel Healthcare Corporation financials
|Revenue TTM||$1.7 billion|
|Operating margin TTM||18.99%|
|Gross profit TTM||$938.4 million|
|Return on assets TTM||9.98%|
|Return on equity TTM||16.2%|
|Market capitalisation||$12.9 billion|
TTM: trailing 12 months
Fisher-and-Paykel Healthcare Corporation share dividends
Dividend payout ratio: 79.61% of net profits
Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 79.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.53% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.53% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.41 per share.
Fisher-and-Paykel Healthcare Corporation's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 December 2023 (the "ex-dividend date").
Have Fisher-and-Paykel Healthcare Corporation's shares ever split?
Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 27 September 2004. So if you had owned 1 share the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.
Fisher-and-Paykel Healthcare Corporation share price volatility
Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $18.426 up to $25.6155. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is 0.409. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares are less volatile than average (for this exchange).
Fisher-and-Paykel Healthcare Corporation overview
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Stocks similar to Fisher-and-Paykel Healthcare Corporation
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert